The forecasted trend for private non-profit expenditure on R&D in medical and health sciences in Canada shows a consistent decline from 2024 to 2028, starting at $54.65 million USD PPP in 2024 and dropping to $51.39 million USD PPP in 2028. The data indicates a steady year-on-year decrease, averaging around 1.5% annually. The compound annual growth rate (CAGR) over the 5-year period is expected to reflect this declining trend.

Future trends to watch for:

Potential policy changes or increased government support that may alter the declining trend.
The impact of technological advancements and emerging health challenges that could drive renewed investment in R&D.
Shifts in non-profit sector funding priorities post-2028, as they could affect long-term investment in health sciences.